BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18765481)

  • 1. Neuropsychological near normality and brain structure abnormality in schizophrenia.
    Wexler BE; Zhu H; Bell MD; Nicholls SS; Fulbright RK; Gore JC; Colibazzi T; Amat J; Bansal R; Peterson BS
    Am J Psychiatry; 2009 Feb; 166(2):189-95. PubMed ID: 18765481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Structure in Neuropsychologically Defined Subgroups of Schizophrenia and Psychotic Bipolar Disorder.
    Woodward ND; Heckers S
    Schizophr Bull; 2015 Nov; 41(6):1349-59. PubMed ID: 25904725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical thickness in neuropsychologically near-normal schizophrenia.
    Cobia DJ; Csernansky JG; Wang L
    Schizophr Res; 2011 Dec; 133(1-3):68-76. PubMed ID: 21981933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric abnormalities associated with cognitive deficits in patients with schizophrenia.
    Wolf RC; Höse A; Frasch K; Walter H; Vasic N
    Eur Psychiatry; 2008 Dec; 23(8):541-8. PubMed ID: 18434103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive performance in schizophrenia: relationship to regional brain volumes and psychiatric symptoms.
    Sanfilipo M; Lafargue T; Rusinek H; Arena L; Loneragan C; Lautin A; Rotrosen J; Wolkin A
    Psychiatry Res; 2002 Nov; 116(1-2):1-23. PubMed ID: 12426030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study.
    Antonova E; Kumari V; Morris R; Halari R; Anilkumar A; Mehrotra R; Sharma T
    Biol Psychiatry; 2005 Sep; 58(6):457-67. PubMed ID: 16039619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study.
    Prasad KM; Eack SM; Goradia D; Pancholi KM; Keshavan MS; Yolken RH; Nimgaonkar VL
    Am J Psychiatry; 2011 Aug; 168(8):822-30. PubMed ID: 21632649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes.
    Mitelman SA; Shihabuddin L; Brickman AM; Hazlett EA; Buchsbaum MS
    Am J Psychiatry; 2003 Dec; 160(12):2154-68. PubMed ID: 14638586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and motor impairments are related to gray matter volume deficits in schizophrenia.
    Sullivan EV; Shear PK; Lim KO; Zipursky RB; Pfefferbaum A
    Biol Psychiatry; 1996 Feb; 39(4):234-40. PubMed ID: 8645769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal and orbital inferior frontal gray matter volume abnormalities and cognitive deficit in treatment-naive, first-episode patients with schizophrenia.
    Guo X; Li J; Wang J; Fan X; Hu M; Shen Y; Chen H; Zhao J
    Schizophr Res; 2014 Feb; 152(2-3):339-43. PubMed ID: 24439000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain volumes as predictor of outcome in recent-onset schizophrenia: a multi-center MRI study.
    van Haren NE; Cahn W; Hulshoff Pol HE; Schnack HG; Caspers E; Lemstra A; Sitskoorn MM; Wiersma D; van den Bosch RJ; Dingemans PM; Schene AH; Kahn RS
    Schizophr Res; 2003 Nov; 64(1):41-52. PubMed ID: 14511800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia.
    Rüsch N; Spoletini I; Wilke M; Bria P; Di Paola M; Di Iulio F; Martinotti G; Caltagirone C; Spalletta G
    Schizophr Res; 2007 Jul; 93(1-3):79-89. PubMed ID: 17383859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A consideration of neuropsychologically normal schizophrenia.
    Allen DN; Goldstein G; Warnick E
    J Int Neuropsychol Soc; 2003 Jan; 9(1):56-63. PubMed ID: 12570358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volume changes in gray matter in patients with schizophrenia.
    Hulshoff Pol HE; Schnack HG; Bertens MG; van Haren NE; van der Tweel I; Staal WG; Baaré WF; Kahn RS
    Am J Psychiatry; 2002 Feb; 159(2):244-50. PubMed ID: 11823266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of cortical thickness and cognition in patients with schizophrenia and healthy controls.
    Ehrlich S; Brauns S; Yendiki A; Ho BC; Calhoun V; Schulz SC; Gollub RL; Sponheim SR
    Schizophr Bull; 2012 Sep; 38(5):1050-62. PubMed ID: 21436318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray matter atrophy in patients with ischemic stroke with cognitive impairment.
    Stebbins GT; Nyenhuis DL; Wang C; Cox JL; Freels S; Bangen K; deToledo-Morrell L; Sripathirathan K; Moseley M; Turner DA; Gabrieli JD; Gorelick PB
    Stroke; 2008 Mar; 39(3):785-93. PubMed ID: 18258824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment course with antidepressant therapy in late-life depression.
    Sheline YI; Disabato BM; Hranilovich J; Morris C; D'Angelo G; Pieper C; Toffanin T; Taylor WD; MacFall JR; Wilkins C; Barch DM; Welsh-Bohmer KA; Steffens DC; Krishnan RR; Doraiswamy PM
    Am J Psychiatry; 2012 Nov; 169(11):1185-93. PubMed ID: 23534057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced white matter integrity as a neural correlate of social cognition deficits in schizophrenia.
    Miyata J; Yamada M; Namiki C; Hirao K; Saze T; Fujiwara H; Shimizu M; Kawada R; Fukuyama H; Sawamoto N; Hayashi T; Murai T
    Schizophr Res; 2010 Jun; 119(1-3):232-9. PubMed ID: 20097045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.